logo
  •  

What research projects have been supported?

Research Supported

Year Research Group Project Title
2017 Australian Advanced School of Medicine Macquarie University Prof Gilles Guillemin
Re-educating” immune cells as a combination therapy to limit breast cancer metastasis
2016 Department of Pathology University of Melbourne Prof Melissa Southey
High Risk Genes for Lobular Breast Cancer
2016 Hunter Medical Research Institute University of Newcastle Dr Michelle Wong-Brown
Analysis of tumours from women with BRCA1 methylation in peripheral blood to assess whether tumour morphology is BRCA1-like
2016 Children's Hospital Westmead University of Sydney A/Prof Sandra Cooper
Myoferlin cleavage – a new marker for metastatic breast cancer?
2016 Southern Cross GeoScience Department Southern Cross University Dr Renaud Joannes-Boyau
Stages of trace element scavenging by invasive and in-situ ductal carcinoma
2016 Hunter Medical Research Institute University of Newcastle Dr Kelly Avery-Kiejda
Is the p53 polymorphism rs17878362 associated with the risk of developing triple-negative breast cancer?
2016 Breast Pathology University of Queensland Centre for Clinical Research Dr Peter Simpson
Defining the genomic and therapeutic landscape of familial breast cancer
2015 School of Biomedical Sciences & Pharmacy University of Newcastle Dr Nicole Verrills
PPP2R2A as a prognostic biomarker
2015 Westmead Institute for Medical Research Universtiy of Sydney Prof Anna de Fazio
Essential clinical annotation for NSW Biobanks through data integration with clinical and administrative datasets – a pilot study
2015 Kolling Institute Universtiy of Sydney Dr Aleksandra Ochknik
Preclinical modelling of new therapies for treatment resistant cancers
2015 Peter MacCallum Cancer Centre Monash Universtiy Dr Kara Britt
Define which cell types within the breast protect against breast cancer
2015 Westmead Institute for Cancer Research University of Sydney Prof Anna DeFazio & Prof Christine Clarke
Essential clinical annotation for NSW Biobanks through data integration with clinical and administrative datasets – a pilot study
2014 The Canberra Hospital Dr Yada Kanjanapan
Benefit of adjuvant trastuzumab with chemotherapy in small (<1cm) node-negative HER 2 positive breast cancer
2014 Triple Negative Breast Cancer Consortium (TNBCC) Mayo Clinic, Rochester, MN, USA. Prof. Fergus J. Couch
OncoArray Study
2014 Australian Breast Cancer Tissue Bank. Prof Jane Dahlstrom
Investigation into the Use of a Digital Image Analysis Tool for Histological Assessment of Biobank Tissue Specimens
2013 St John of God Hospital Subiaco Western Australia. Dr Libby Thomas
Investigation of FOXP3 and RANKL in tumour-infiltrating T cells and diagnostic marker discovery in locally-advanced and metastatic breast cancer.
2013 Bone Research Program ANZAC Research Institute,University of Sydney. A/Prof Colin R Dunstan
The Vitamin D Receptor Regulates Breast Cancer Growth and Malignant Potential: A Novel Cytoplasmic F
2013 Centre for Information-Based Medicine Hunter Medical Research Institute (HMRI)John Hunter Hospital, Newcastle. Prof Rodney Scott
Epigenetics and breast cancer biomarkers
2013 Breast Cancer Association Consortium(BCAC) Hunter Medical Research Institute (HMRI) John Hunter Hospital, Newcastle. Prof Rodney Scott
OncoArray Study
2012 Kolling Institute, Sydney. Dr Efty Stavrou
Molecular subtype breast cancer in the ABCTB
2012 School of Surgery EII Medical Centre The University of Western Australia. Professor Christobel Saunders
Targeting Breast Cancer Recurrence through Epithelial Mesenchymal Plasticity
2012 Kolling Institute, Sydney. Dr Efty Stavrou
Molecular subtype breast cancer in the ABCTB
2011 Westmead Millenium Institute Sydney. Dr. Heidi Hilton
The impact of aberrant progesterone signalling on lineage specification during early malignant transformation
2011 Breast Pathology University of Queensland Centre for Clinical Research. Dr. Peter Simpson
Expression Analyses of Invasive Lobular Carcinomas.
2011 John Hunter Hospital, Newcastle. Mrs Katherine Bolton
Role of Tandem Repeats on the Risk of Breast Cancer
2011 Department of Immunology and Translational Research The Canberra Hospital Assoc. Prof. Matthew Cook
Candidate miRNA in breast cancer.
2011 School of Biomedical Sciences & Pharmacy University of Newcastle. Dr Judith Weidenhofer
Investigation of the control of tetraspanin expression in breast cancer: implications for biomarker discovery.
2011 Peter MacCallum Cancer Centre, Melbourne. A/Prof Ian G Campbell
High resolution genome-wide genomic analysis of breast cancer precursor lesions to identify markers
2011 Centre for Information-Based Medicine Hunter Medical Research Institute (HMRI) John Hunter Hospital, Newcastle Prof Rodney Scott
Genetic Variation in Breast Cancer
2010 Medical Oncology Westmead Hospital, Sydney. Dr Rosemary Balleine
Molecular grade as prognostic indicator in invasive breast cancer.
2010 Hunter Area Pathology Service John Hunter Hospital, Newcastle. Prof. Rodney Scott
The role of p53 isoforms in breast cancer progression
2010 Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Sydney. Dr. Sandra O'Toole
Molecular biomarkers of prognosis and treatment response in breast cancer.
2010 Hormones and Cancer Group, Kolling Institute. Prof Robert Baxter
Discovery of serum biomarkers for breast cancer
2010 Australian Centre for Microscopy & Microanalysis The University of Sydney. Dr. Lillian Soon.
Characterisation of invasive tumour cells
2009 Cancer Genetics Kolling Institute, Sydney. Dr Patsy Soon
The role of microRNAs in the progression of ductal carcinoma in situ to invasive breast cancer
2009 Mayo Clinic, Rochester, MN, USA. Prof. Fergus J. Couch
Genetic epidemiology of triple negative breast cancer
2009 Cancer Genetics Kolling Institute, Sydney. Dr Patsy Soon
Correlation of serum miRNAs in breast cancer patients with clinical parameters
2008 Tumour Progression Group The Garvan Institute. Dr Alexander Swarbrick
The role of Id1 in breast cancer initiating cells
2008 National Breast Cancer Foundation Collaborative Program. Project Manager, Dr Elizabeth Kuczek
Identification of nuclear receptor (NR) networks active in breast cancers, to establish new predictive and therapeutic targets in women currently underserved by existing treatments, including young women with ER-PR-, or women with metastatic disease.
2008 Centenary Institute - Vascular Biology Program Tumour Senescence Group. Dr Matthew Grimshaw
Vascular senescence in breast tumour progression.
2008 Breast Cancer Association Consortium. Prof. Georgia Chenevix-Trench
Collaborative Oncological Gene- environment study (COGS) - Polymorphisms associated with breast tumour subtypes and outcome
2008 Hormones and Cancer Group Kolling Institute, Sydney. Prof. Robert Baxter
The use of SELDI-TOF MS for biomarker discovery in breast cancer tissue.